We report the case of a 65-year-old man who presented with epigastric pain and guaic-positive stool. Upper and lower endoscopy revealed abnormalities in the gastric antrum and terminal ileum. Biopsy of these sites revealed histologically and immunophenotypically distinct lymphomas: gastric extranodal marginal zone lymphoma in the background of Helicobacter pylori infection and follicular lymphoma of the terminal ileum. After treatment with an H. pylori eradication regimen, repeat endoscopy showed resolution of the gastric extranodal marginal zone lymphoma and persistence of the ileal follicular lymphoma. Interestingly, molecular studies performed on the biopsy specimens revealed a common IgH rearrangement, suggesting a common precursor cell responsible for these two malignant processes. We present this unique case with a review of the literature, highlighting treatment principles for these two subtypes of indolent gastrointestinal non-Hodgkin lymphoma.
INTRODUCTION
Extranodal marginal zone lymphoma of mucosaassociated lymphoid tissue (MALT) is a B-cell neoplasm that constitutes approximately 7% to 8% of all non-Hodgkin lymphomas. MALT lymphomas can arise from almost any organ in the body, although roughly 50% arise from the gastrointestinal tract with one third of these affecting the stomach. Chronic inflammation frequently precedes or accompanies MALT lymphoma and may be the result of a variety of stimuli. Typical of gastric MALT lymphoma is a well-documented association with Helicobacter pylori infection and a 50% to 80% complete regression rate after eradication of this infection. [1] [2] [3] [4] The incidence of gastric MALT lymphoma may be decreasing because treatment aimed at eradication of H. pylori has become increasingly used. 5 Primary gastrointestinal follicular lymphoma without peripheral lymphadenopathy is very uncommon, accounting for less than 7% of primary lymphomas of the gastrointestinal tract. Small series characterize these tumors as having a predilection for the second part of the duodenum and the terminal ileum. Prognosis may be excellent, even without treatment. [6] [7] [8] We present a case of a patient presenting with simultaneous gastric MALT lymphoma associated with H. pylori infection and follicular lymphoma of the terminal ileum. To our knowledge, there have been only two previously reported cases of coexisting primary gastrointestinal follicular lymphoma with gastrointestinal MALT lymphoma 9, 10 and no previously reported cases of ileal follicular lymphoma simultaneously presenting with gastric MALT lymphoma. In our patient, after treatment of the H. pylori gastritis, there was regression of the MALT lymphoma with persistence of the ileal follicular lymphoma. Interestingly, despite clear clinical and immunophenotypic differences in the two lymphomas, molecular analysis for IgH rearrangement showed a same-sized peak in both tumors. In light of this finding, this case may represent evolution of two distinct but clonally related lymphomas from a single precursor. A similar case has been reported in a patient who developed follicular lymphoma 2 years after being diagnosed with MALT lymphoma in the parotid gland. 11 
CASE REPORT
A 65-year-old man presented to his primary care doctor for symptoms of increasing reflux in the setting of long-term gastroesophageal reflux disease. He also at the time of evaluation began to experience mild dysphagia to solid foods. Initial evaluation was significant for positive fecal occult blood. He underwent evaluation with upper and lower endoscopy. Upper endoscopy showed an area of nodular, ulcerated tissue in the gastric antrum with a background of diffuse erythema in the stomach and duodenum. Biopsy was taken of the antral nodule. Colonoscopy showed an isolated patch of erythematous mucosa at the terminal ileum and biopsy of this area was taken. The pathologic findings are reviewed subsequently.
Staging was performed with computed tomography and positive emission tomography. Imaging showed a 1.4-cm para-aortic lymph node that was mildly (standardized uptake value 3.16) positive emission tomography-avid. There additionally were multiple subcentimeter positive emission tomography-negative mesenteric lymph nodes.
He was treated with anti-H. pylori therapy consisting of amoxicillin, clarithromycin, and a proton pump inhibitor. Presenting symptoms of worsening reflux and dysphagia resolved with this treatment. Repeat upper and lower endoscopy was performed approximately 6 weeks after completion of therapy. Upper endoscopy showed successful H. pylori eradication and complete resolution of the antral lesion; multiple biopsies near the site showed no residual disease. Colonoscopy showed a residual terminal ileum lesion and repeat biopsy showed persistent follicular lymphoma involvement. No further treatment was undertaken for the follicular lymphoma because it was felt to be an asymptomatic incidental finding. Surveillance computed tomography imaging was performed 6 months and 1 year after diagnosis and showed stable subcentimeter mesenteric lymphadenopathy unchanged from the previous evaluation.
MATERIALS AND METHODS

Tissue samples and immunohistochemistry
Biopsies were fixed in 10% neutral-buffered formalin, embedded in paraffin, and stained with hematoxylineosin.
A panel of immunohistochemical stains (CD20, CD5, CD10, CD23, CD43, Bcl-2, Bcl-6, and cyclin D1) were performed using commercially available antibodies on formalin-fixed paraffin-embedded sections according to previously published techniques. 12, 13 Immunoglobulin polymerase chain reaction DNA extraction was performed on formalin-fixed paraffin-embedded with the QiaCUBE extraction platform using their proprietary buffer and proteinase K digestion. Polymerase chain reaction (PCR) was performed using consensus primers directed to V H framework (FR) III and joining region (J H ) of the immunoglobulin heavy chain gene (FRIII-IGH PCR) and to V H FR region II and the joining region (FRII-IGH PCR), according to the method of Ramasamy et al. 14 Testing for the IGk locus was additionally performed using the Biomed II primer set described by van Dongen et al and supplied by InVivoScribe Technologies (IGK@ Gene Clonality Assay-ABI Fluorescence Detection, Catalog No. 1-102-0031). 15 These reactions interrogate rearrangements involving the Vk loci and Jk (tube A), the Vk locus and the kDE locus (tube B), and the k-intron RSS locus and the kDE locus (tube B). The products from all reactions were separated by capillary electrophoresis on an ABI 3130xl Genetic Analyzer and the electropherograms analyzed using GeneMapper software Version 3.7 (ABI).
Fluorescence in situ hybridization
Formalin-fixed paraffin-embedded sections were pretreated (deparaffinization, protein digestion, and DNA neutralization) and hybridized using the Vysis IGH/BCL2 t(14;18)(q32;21) dual color, dual fusion translocation probe set from Abbott Molecular, Inc (Downers Grove, IL). Quantitative analysis of the images was performed manually on selected tissue areas with the Bioview image system (Billerica, MA). Positive cases for detection were defined when fusion signals were greater than 11.55%.
RESULTS
The antral biopsy showed a dense atypical proliferation of B-cells (CD20-positive) in the lamina propria and focal lymphoepithelial lesions in a background of active chronic gastritis (Fig. 1) . These cells were negative for CD5, CD10, CD23, CD43, Bcl-2, Bcl-6, or cyclin D1. Micro-organisms consistent with H. pylori were present on special stain. A diagnosis of extranodal marginal zone lymphoma of MALT lymphoma was rendered.
Terminal ileum biopsy showed a vaguely nodular monotonous atypical lymphoid infiltrate in the lamina propria (Fig. 2) . Immunohistochemical analysis showed the atypical cells were positive for CD20, Bcl-2, CD10, and Bcl-6 and negative for CD5, CD23, CD43, and cyclin D1. A diagnosis of follicular lymphoma, Grade 1 to 2, was rendered.
Molecular studies were performed on samples from both sites. Fluorescence in situ hybridization for t(14;18) BCL/IGH was performed and was positive in the terminal ileum biopsy and suggestive but indeterminate in the antral gastric sample. Further PCR for IgH and IgK rearrangements revealed an identically sized fragment (258-259 base-pair size) in both biopsy sites at the FRII-IgH locus, suggesting a clonal relationship (Fig. 3A-B ).
DISCUSSION
The gastrointestinal tract is the most common extranodal primary site for non-Hodgkin lymphoma, accounting for 40% of cases. The stomach is the most commonly involved site; this is particularly true for gastrointestinal MALT lymphomas where 85% arise in the stomach. 16, 17 MALT lymphoma is mainly a tumor of adults with a slight female predominance. The incidence of gastric MALT lymphoma declined in the late 1990s, possibly associated with the increased treatment for H. pylori infection, but has since leveled. 5, 18 MALT lymphomas appear to arise from postgerminal center marginal zone B cells and have a typical immunophenotype: positive for B cell markers CD19, CD20, and CD22 and negative for CD5, CD10, and usually CD23. 19 Cytogenetic abnormalities are common in MALT lymphoma. Most common are trisomy 3 and four translocations, t(11;18)(q21;q21), t(1;14)(p22;q32), t(14;18)(q32;q21), and t(3;14)(p13;q32). [20] [21] [22] Interestingly, the genes affected by these translocations seem to involve a similar pathway, leading to the activation of nuclear factor-kappaB. 23 MALT lymphomas tend to be indolent lesions, although approximately 30% can present with dissemination to other MALT sites, lymph nodes, or bone marrow. However, even patients with disseminated disease at presentation tend to have long periods (greater than 5 years) of progression-free survival. 24 The majority of gastric MALT lymphomas are associated with H. pylori infection. Despite lack of prospective randomized trials, H. pylori eradication has emerged as the preferred treatment in this situation because of its low toxicity and high efficacy. With this treatment, 50% to 80% of cases achieve complete remission on repeat endoscopy and biopsy. [1] [2] [3] [4] Of note, patients whose tumors demonstrate t(11:18) tend to behave more aggressively and are much less likely to respond to H. pylori eradication. 3, 25, 26 Therefore, this subset of patients may be considered for alternate, more aggressive treatment strategies.
Follicular lymphoma is the most common indolent non-Hodgkin lymphoma; however, primary gastrointestinal follicular lymphoma is uncommon. 6, 7 The immunology, immunophenotype, and molecular genetics of gastrointestinal follicular lymphoma are similar to the nodal counterpart. 6, 7, 27 Typical follicular lymphomas express pan-B cell antigens (CD19, CD20, CD79a), CD10 (majority), Bcl-2, and Bcl-6 and lack CD5, CD43 (most cases), and CD11c. Both nodal and gastrointestinal follicular lymphoma frequently have the t(14;18)(q32;q21) translocation 27, 28 ; other cytogenetic abnormalities are less common.
Optimal treatment of primary gastrointestinal follicular lymphoma is not well established as a result of the relative rarity of this disease. Retrospective analysis, however, suggests an indolent disease course and excellent prognosis, including in cases in which therapy was not initiated at the time of diagnosis. 6, 7, 27 These findings suggest watchful waiting as a reasonable approach in this patient population.
To our knowledge, this is the first reported case of primary ileal follicular lymphoma coexisting with gastric MALT lymphoma. This case highlights the indolent nature of these two diseases and the role for a conservative treatment approach. Interestingly, despite clear clinical and immunophenotypic differences between the two tumors in this patient, both lymphomas were found to have a clonally identical IgH rearrangement suggesting a common precursor cell. These findings suggest that an important interplay exists between local microenvironment such as H. pylori infection and genetics in the development of gastrointestinal low-grade B-cell lymphomas.
